Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort study.
Children
Diagnosis
Severe acute malnutrition
Treatment decision algorithms
Tuberculosis
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
20
12
2023
revised:
24
05
2024
accepted:
30
05
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
epublish
Résumé
In children with severe acute malnutrition (SAM) tuberculosis is common, challenging to diagnose, and often fatal. We developed tuberculosis treatment decision algorithms (TDAs) for children under the age of 5 years with SAM. In this prospective diagnostic study, we enrolled and followed up children aged <60 months hospitalised with SAM at three tertiary hospitals in Zambia and Uganda from 4 November 2019 to 20 June 2022. We included children aged 2-59 months with SAM as defined by WHO and hospitalised following the WHO clinical criteria. We excluded children with current or history of antituberculosis treatment within the preceding 3 months. They underwent tuberculosis symptom screening, clinical assessment, chest X-ray, abdominal ultrasound, Xpert MTB/RIF Ultra (Ultra) and culture on respiratory and stool samples with 6 months follow-up. Tuberculosis was retrospectively defined using the 2015 standard case definition for childhood tuberculosis. We used logistic regression to develop diagnostic prediction models for a one-step diagnosis and a two-step screening and diagnostic approaches. We derived scores from models using WHO-recommended thresholds for sensitivity and proposed TDAs. This study is registered with ClinicalTrials.gov, NCT04240990. Of 1906 children hospitalised with SAM during the study period, 1230 were screened, 1152 were eligible and 603 were enrolled. Of the 603 children enrolled-median age 15 (inter-quartile range (IQR): 11-20) months and 65 (11.0%) living with HIV-114 (18.9%) were diagnosed with tuberculosis, including 51 (8.5%) with microbiological confirmation and 104 (17.2%) initiated treatment at a median of 6(IQR: 2-10) days after inclusion. 108 children were retrospectively classified as having tuberculosis resulting in a prevalence of 17.9% (95% confidence intervals (CI): 15.1; 21.2). 75 (69.4%) children with tuberculosis reported cough of any duration, 32 (29.6%) cough ≥2 weeks and 11 (10.2%) tuberculosis contact history. 535 children had complete data and were included in the diagnostic prediction model. The one-step diagnostic model had 15 predictors, including Ultra, clinical, radiographic, and abdominal features, an area under the receiving operating curve (AUROC) of 0.910, and derived TDA sensitivity of 86.14% (95% CI: 78.07-91.56) and specificity of 80.88% (95% CI: 76.91-84.30). The two-step model had AUROCs of 0.750 and 0.912 for screening and diagnosis, respectively, and derived combined TDA sensitivity of 79.21% (95% CI: 70.30-85.98) and a specificity of 83.64% (95% CI: 79.87-86.82). Tuberculosis prevalence was high among hospitalised children with SAM, with atypical clinical features. TDAs achieved satisfactory diagnostic accuracy and could be used to improve diagnosis in this vulnerable group. Unitaid.
Sections du résumé
Background
UNASSIGNED
In children with severe acute malnutrition (SAM) tuberculosis is common, challenging to diagnose, and often fatal. We developed tuberculosis treatment decision algorithms (TDAs) for children under the age of 5 years with SAM.
Methods
UNASSIGNED
In this prospective diagnostic study, we enrolled and followed up children aged <60 months hospitalised with SAM at three tertiary hospitals in Zambia and Uganda from 4 November 2019 to 20 June 2022. We included children aged 2-59 months with SAM as defined by WHO and hospitalised following the WHO clinical criteria. We excluded children with current or history of antituberculosis treatment within the preceding 3 months. They underwent tuberculosis symptom screening, clinical assessment, chest X-ray, abdominal ultrasound, Xpert MTB/RIF Ultra (Ultra) and culture on respiratory and stool samples with 6 months follow-up. Tuberculosis was retrospectively defined using the 2015 standard case definition for childhood tuberculosis. We used logistic regression to develop diagnostic prediction models for a one-step diagnosis and a two-step screening and diagnostic approaches. We derived scores from models using WHO-recommended thresholds for sensitivity and proposed TDAs. This study is registered with ClinicalTrials.gov, NCT04240990.
Findings
UNASSIGNED
Of 1906 children hospitalised with SAM during the study period, 1230 were screened, 1152 were eligible and 603 were enrolled. Of the 603 children enrolled-median age 15 (inter-quartile range (IQR): 11-20) months and 65 (11.0%) living with HIV-114 (18.9%) were diagnosed with tuberculosis, including 51 (8.5%) with microbiological confirmation and 104 (17.2%) initiated treatment at a median of 6(IQR: 2-10) days after inclusion. 108 children were retrospectively classified as having tuberculosis resulting in a prevalence of 17.9% (95% confidence intervals (CI): 15.1; 21.2). 75 (69.4%) children with tuberculosis reported cough of any duration, 32 (29.6%) cough ≥2 weeks and 11 (10.2%) tuberculosis contact history. 535 children had complete data and were included in the diagnostic prediction model. The one-step diagnostic model had 15 predictors, including Ultra, clinical, radiographic, and abdominal features, an area under the receiving operating curve (AUROC) of 0.910, and derived TDA sensitivity of 86.14% (95% CI: 78.07-91.56) and specificity of 80.88% (95% CI: 76.91-84.30). The two-step model had AUROCs of 0.750 and 0.912 for screening and diagnosis, respectively, and derived combined TDA sensitivity of 79.21% (95% CI: 70.30-85.98) and a specificity of 83.64% (95% CI: 79.87-86.82).
Interpretation
UNASSIGNED
Tuberculosis prevalence was high among hospitalised children with SAM, with atypical clinical features. TDAs achieved satisfactory diagnostic accuracy and could be used to improve diagnosis in this vulnerable group.
Funding
UNASSIGNED
Unitaid.
Identifiants
pubmed: 39007063
doi: 10.1016/j.eclinm.2024.102688
pii: S2589-5370(24)00267-0
pmc: PMC11245985
doi:
Banques de données
ClinicalTrials.gov
['NCT04240990']
Types de publication
Journal Article
Langues
eng
Pagination
102688Investigateurs
Olivier Marcy
(O)
Angeline Serre
(A)
Anne Badrichani
(A)
Manoa Razafimanantsoa
(M)
Julien Poublan
(J)
Aurélia Vessière
(A)
Clémentine Roucher
(C)
Estelle Occelli
(E)
Aurélie Beuscart
(A)
Aurélie Charpin
(A)
Gemma Habiyambere
(G)
Salomé Mesnier
(S)
Eric Balestre
(E)
Nicolas Koskas
(N)
Marc D'Elbée
(M)
Hélène Font
(H)
Minh Huyen Ton Nu Nguyet
(MH)
Maryline Bonnet
(M)
Manon Lounnas
(M)
Hélène Espérou
(H)
Sandrine Couffin-Cadiergues
(S)
Alexis Kuppers
(A)
Benjamin Hamze
(B)
Eric Wobudeya
(E)
Gerald Bright Businge
(GB)
Faith Namulinda
(F)
Robert Sserunjogi
(R)
Rashidah Nassozi
(R)
Charlotte Barungi
(C)
Aanyu Hellen
(A)
Muwonge Doreen
(M)
Eva Kagoya
(E)
Serene Aciparu
(S)
Chemutai Sophia
(C)
Samuel Ntambi
(S)
Amir Wasswa
(A)
Juliet Nangozi
(J)
Chishala Chabala
(C)
Veronica Mulenga
(V)
Perfect Shankalala
(P)
Chimuka Hambulo
(C)
Vincent Kapotwe
(V)
Marjory Ngambi
(M)
Kunda Kasakwa
(K)
Mirriam Kanyama
(M)
Uzima Chirwa
(U)
Kapula Chifunda
(K)
Gae Mundundu
(G)
Susan Zulu
(S)
Grace Nawakwi
(G)
Teddy Siasulingana
(T)
Diana Attan Himwaze
(DA)
Jessy Chilonga
(J)
Maria Chimbini
(M)
Mutinta Chilanga
(M)
Daniel Chola
(D)
Eustace Mwango
(E)
Bwendo Nduna
(B)
Muleya Inambao
(M)
Mwamba Pumbwe
(M)
Mwate Mwambazi
(M)
Barbara Halende
(B)
Wyclef Mumba
(W)
Endreen Mankunshe
(E)
Maureen Silavwe
(M)
Moses Chakopo
(M)
Roy Moono
(R)
Chalilwe Chungu
(C)
Kevin Zimba
(K)
Monica Kapasa
(M)
Khozya Zyambo
(K)
Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
All authors declare no competing interests.